Key terms
About SLP
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The firm operates through the Software and Services segment. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SLP news
Yesterday
9:20am ET
Analysts Offer Insights on Healthcare Companies: PAVmed (PAVM) and Simulations Plus (SLP)
Mar 05
9:11am ET
FDA awards Simulations Plus a grant through proposal with University of Bath
Feb 28
5:55am ET
Simulations Plus management to meet with Oppenheimer
Feb 27
4:55am ET
Simulations Plus management to meet with Oppenheimer
Feb 20
8:37am ET
Simulations Plus management to meet with Oppenheimer
Feb 15
9:05am ET
Simulations Plus extends pact with Translational Toxicology Division at NIEHS
Feb 13
9:32am ET
Simulations Plus to Present at Oppenheimer Conference
Feb 12
4:13pm ET
Simulations Plus Shareholders Elect Board, Boost Growth Plan
Jan 09
8:37am ET
Simulations Plus teams with NEU and The TIM Company through new FDA grant
Jan 04
8:58am ET
Simulations Plus price target raised to $51 from $50 at Craig-Hallum
Jan 04
6:00am ET
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Immunome (IMNM) and Simulations Plus (SLP)
Jan 03
4:09pm ET
Simulations Plus names Will Frederick COO, Dan Szot CRO
Jan 03
4:08pm ET
Simulations Plus backs FY24 EPS view 66c-68c, consensus 67c
Jan 03
4:07pm ET
Simulations Plus reports Q1 EPS 10c, consensus 10c
Jan 03
9:06am ET
Craig-Hallum Reaffirms Their Buy Rating on Simulations Plus (SLP)
Jan 02
9:44am ET
BTIG Remains a Buy on Simulations Plus (SLP)
Dec 31
5:23am ET
BTIG Remains a Buy on Simulations Plus (SLP)
No recent news articles are available for SLP
No recent press releases are available for SLP
SLP Financials
Key terms
Ad Feedback
SLP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SLP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range